[Special Stock] President Moon's Interest in Syringes... Samsung Pharm Soars 14%

[Asia Economy Reporter Lee Seon-ae] Samsung Pharmaceutical is experiencing a sharp rise.

As of 9:16 AM on the 19th, Samsung Pharmaceutical is trading at 9,040 KRW, up 14.72% from the previous day. Earlier in the session, it rose to 9,360 KRW. This is interpreted as being influenced by news of President Moon Jae-in's inspection of the production process of syringes at Punglim Pharmatech.

On the 18th, President Moon visited the LDS syringe production process at Punglim Pharmatech located in Gunsan, Jeonbuk, stating, "The world’s attention is focused on the low dead space syringes that can vaccinate one more person per vaccine vial," and added, "Our small and medium enterprises, Punglim Pharmatech, Shina Yanghaeng, and Dowon Meditech, have once again demonstrated the excellence of K-quarantine following diagnostic kits."

Accordingly, at the same time, syringe-related companies such as Sewoon Medical, Inno Therapy, Shinshin Pharmaceutical, and Lapas are also showing upward trends.

This content was produced with the assistance of AI translation services.